Xeris Biopharma Holdings, Inc. (XERS)

Last Closing Price: 6.51 (2025-12-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Xeris Biopharma Holdings, Inc. (XERS) had Net Income of $0.62M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$74.38M
Net Income
$0.62M
$11.00M
$63.38M
$67.65M
$6.73M
$-6.11M
$0.62M
$0.62M
$0.62M
$0.62M
$0.62M
$0.62M
$6.73M
$10.76M
163.65M
177.62M
$0.00
$0.00
Balance Sheet Financials
$224.02M
$4.95M
$146.17M
$370.19M
$116.20M
$219.47M
$254.85M
$371.05M
$-0.86M
$-114.51M
$-0.86M
165.53M
Cash Flow Statement Financials
$8.58M
$-0.36M
$11.65M
$75.74M
$95.62M
$19.88M
$17.09M
--
--
Fundamental Metrics & Ratios
1.93
--
--
1.00
-254.90
85.22%
9.05%
9.05%
--
0.83%
0.83%
$8.22M
--
--
--
0.20
0.16
1.38
65.04
-72.13%
-0.54%
0.17%
0.28%
$-0.01
$0.05
$0.05